NOVUMED is an independent strategy consulting & advisory services firm for the life sciences industry. With offices in the US and Europe, NOVUMED is one of the few global advisors with a clear industry focus. The experienced management consultants and the advisory team support life science companies, industry groups and investors in the preparation and implementation of market strategies, innovation strategies and strategic financial transactions. Consulting NOVUMED helps to prioritize potential markets and creates transparency whether an investment in a new market is attractive. Combining privileged data access with consulting services, we provide deeper and more precise analyses for your market access strategy or sales force effectiveness. NOVUMEDsupports your sales team in developing an aggressive marketing strategy based on detailed analysis of the market potential and an in-depth understanding of customer requirements. We intensify your business development by target scouting, finding the right partner and hands-on sales lead generation. Advisory To help our clients make strategic decisions, we apply complex statistical, quantitative, financial and business analyses as part of our product licensing and sales advisory. Robust financial models enable our clients to make well-informed decisions. Our Advisory group provides strategic alternative services worldwide, ranging from acquisitions and divestitures to restructurings and special committee assignments. Data NOVUMED has access to pharmaceutical data from wholesalers or pharmacy panels in the US, Germany, Austria, Russia and many more. We use comprehensive patent databases that cover >85% of the global market. We either leverage this information in our consulting projects or we assist you to identify the crucial data for your analysis. Our customized databases help our clients to identify in-licensing or M&A opportunities, to find partners, new clients or acquisition targets.
